Response to: Enhancing Clinical Practice: Critical Insights for Medical Workers in Applying Pembrolizumab for Metastatic NSCLC and Pembrolizumab, Chemotherapy and Metastatic Non-Small Cell Lung Cancer
J Thorac Oncol
.
2025 Jan;20(1):e11-e12.
doi: 10.1016/j.jtho.2024.10.015.
Authors
Shirish M Gadgeel
1
,
Erin Jensen
2
,
Mark Shamoun
2
,
Kumar Rajagopalan
2
Affiliations
1
Henry Ford Cancer Institute, Detroit, Michigan. Electronic address: sgadgee1@hfhs.org.
2
Merck & Co., Inc., Rahway, New Jersey.
PMID:
39794106
DOI:
10.1016/j.jtho.2024.10.015
No abstract available
Publication types
Letter